Zhi-Ying James Fang

Jim Fang has more than 25 years of experience in China-related international business transactions. He represents U.S. and international manufacturing and private equity clients with structuring, documenting and negotiating strategic alliances, mergers and acquisitions, joint ventures, corporate restructuring, asset-based financing, and equipment leasing. In addition, Jim regularly provides advice in intellectual property protection strategies and in handling troubled business workouts in China.

Jim also represents China-based companies doing business in the U.S. Given his profound understanding of the culture, business and legal systems in both China and the U.S., Jim provides his clients with valuable insight regarding their investments. Jim is one of the founders of the firm's Shanghai office.

Jim assists clients in an array of industries, including financial, insurance, automobile, retail, chemical, semiconductor, clean energy, machinery, technology, and pharmaceutical. His clients include: Bank of China, China Eastern Airlines, Genencor International, W.L. Gore & Associates, The Timken Company, and WPMI LLC, a WellPoint company.

Practice Highlights

• Counseling companies and their management teams in a number of preference share financing transactions
• Assisting U.S. manufacturers in merger and acquisition transactions of various types, including asset purchase and equity acquisition, particularly in equity acquisition by subscribing capital increase and partner buyout/sellout, in both the state-owned and private sectors
• Counseling on the structure and exit strategies of a private-equity investment green-energy project
• Helping U.S. biotech and manufacturing clients with complex corporate restructuring projects in China, featuring simultaneous closing of three interdependent transactions: buyout, sales of existing facilities to the government and relocation, and tax planning
• Representing U.S. energy companies in a complicated administrative proceeding before customs and other regulatory agencies, involving the seizure of inventory, resulting in inventory return
• Representing U.S. manufacturers in negotiation and documentation for a strategic alliance and joint venture investment projects in various locations in China
• Instructor for various training programs of clients on business ethics, anti-trust law and business concepts
• Regularly serving as an expert witness in a number of proceedings on a variety of subjects concerning Chinese law